Use of prostate specific antigen to measure bladder tumor growth in a mouse orthotopic model

Journal of Urology

Volumn 172, Issue 6 I, 2004, Pages 2414-2420

  Luo, Yi ^a   Chen, Xiaohong ^a   O'Donnell, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Bladder; Bladder neoplasms; Carcinoma, transitional cell; Mice; Prostate specific antigen

Indexed keywords

GEMCITABINE; MITOMYCIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR MODEL;

EID: 8644286350     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000143860.50878.b1     Document Type: Article

References (20)

1. Jemal, A., Murry, T., Samuels, A., Ghafoor, A., Ward, E. and Thun, M. J.: Cancer statistics, 2003. CA Cancer J Clin, 53: 5, 2003
2. Messing, E. M., Young, T. B., Hunt, V. B., Gilchrist, K. W., Newton, M. A., Bram, L. L. et al: Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology, 45: 387, 1995
3. Millán-Rodríguez, F., Chéchile-Toniolo, G., Salvador-Bayarri, J., Palou, J., Algaba, F. and Vicente-Rodríguez, J.: Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol, 164: 680, 2000
4. de Vere White, R. W. and Stapp, E.: Predicting prognosis in patients with superficial bladder cancer. Oncology, 12: 1717, 1998
5. Soloway, M. S., deKernion, J. B., Rose, D. and Persky, L.: Effect of chemotherapeutic agents on bladder cancer: a new animal model. Surg Forum, 24: 542, 1973
6. Summerhayes, I. C. and Franks, L. M.: Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. J Natl Cancer Inst, 62: 1017, 1979
7. Mickey, D. D., Mickey, G. H., Murphy, W. M., Niell, H. B. and Soloway, M. S.: In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors. J Urol, 127: 1233, 1982
8. Soloway, M. S.: Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res, 37: 2918, 1977
9. Torti, S. V., Golden-Fleet, M., Willingham, M. C., Ma, R., Cline, M., Sakimoto, Y. et al: Use of green fluorescent protein to measure tumor growth in an implanted bladder tumor model. J Urol, 167: 724, 2002
10. Burchardt, M., Burchardt, T., Shabsigh, A., De La Taille, A., Benson, M. C. and Sawczuk, I.: Current concepts in biomarker technology for bladder cancers. Clin Chem, 46: 595, 2000
11. Mazurchuk, R., Glaves, D. and Raghavan, D.: Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer. Clin Cancer Res, 3: 1635, 1997
12. Alexander, A. A., Liu, J.-B., McCue, P., Gomella, L. G., Ross, R. P. and Lattime, E. C.: Intravesical growth of murine bladder tumors assessed by transrectal ultrasound. J Urol, 150: 525, 1993
13. Yang, M., Baranov, E., Jiang, P., Sun, F. X., Li, X. M., Li, L. et al: Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA, 97: 1206, 2000
14. Heim, R., Prasher, D. C. and Tsien, R. Y.: Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci USA, 91: 12501, 1994
15. Kneen, M., Farinas, J., Li, Y. and Verkman, A. S.: Green fluorescent protein as a noninvasive intracellular pH indicator. Biophys J, 74: 1591, 1998
16. O'Donnell, M. A., Luo, Y., Hunter, S. E., Chen, X., Hayes, L. L. and Clinton, S. K.: Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity. J Urol, 171: 1330, 2004
17. O'Donnell, M. A., Luo, Y., Hunter, S. E., Chen, X., Hayes, L. L. and Clinton, S. K.: The essential role of interferon-γ during interleukin-12 therapy of murine transitional cell carcinoma of the bladder. J Urol, 171: 1336, 2004
18. Hoffman, R. M.: Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis Rev, 17: 271, 1998
19. Hudson, M. A., Ritchey, J. K., Catalona, W. J., Brown, E. J. and Ratliff, T. L.: Comparison of the fibronectin-binding ability and antitumor efficacy of various mycobacteria. Cancer Res, 50: 3843, 1990
20. Gunther, J. H., Jurczok, A., Wulf, T., Brandau, S., Deinert, I., Jocham, D. et al: Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res, 59: 2834, 1999